The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes
Open accessAbstract
A 69-year old man, from Lombardy, Italy, was admitted to our unit because of acute respiratory distress syndrome that required mechanical ventilation; he was in Nice, France, on holiday. He had previously been fit and well; he had a history of hypertension controlled with bisoprolol 2·5 mg/day. He initially reported vomiting and diarrhoea, and 7 days afterwards, he came to our emergency department with a cough, fever of 39°C, and dyspnoea. He was immediately transferred to our intensive care unit (ICU) because of the respiratory distress syndrome and severe hypoxia. Investigations found a haemoglobin concentration of 15·4 g/dL, a platelet count of 187 × 109 per L, and a leucocyte count of 14·9 × 109 per L (neutrophils 89%, lymphocytes 7%, monocytes 4%, and no eosinophils or basophils 0%). His blood pH was 7·27, partial pressure of carbon dioxide was 45·3 mm Hg, partial pressure of oxygen was 146 mm Hg, and peripheral oxygen saturation was 98·2%. A CT of his chest showed bilateral ground-glass opacities and condensations (figure; video). PCR of swabs taken from his upper respiratory tract showed severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) con firming a diagnosis of coronavirus disease 19 (COVID-19). Multiplex PCR was negative for other viruses using BioFire FilmArray Respiratory Panel 2 plus (bioMérieux, Marcy l’Etoile, France) and no bacterial infections were found. An electrocardiogram (ECG), done on admission to the ICU, showed signs of left ventricular hypertrophy (LVH) and diffuse inverted T waves (figure)—a previous ECG showed inverted T waves in anterior leads only. High-sensitivity cardiac troponin I concentration was raised at 9002 ng/L (normal <40). Transthoracic echocardiography showed mild LVH; the left ventricular ejection fraction and wall motion were within normal limits (figure; video). The patient was known to have LVH which was probably caused by his chronic hypertension. Antiplatelet therapy—aspirin—and anticoagulation therapy—fondaparinux—were started because we suspected a non-ST elevation myocardial infarction: his Global Registry of Acute Coronary Events (GRACE) score was greater than 140. However, coronary angiography showed no disease, but cardiovascular magnetic reso nance scanning showed subepicardial late gadolinium enhancement of the apex and inferolateral wall—suggestive of myocarditis (figure; video). We decided not to do an endomyocardial biopsy because the patient showed no signs of heart failure or arrhythmias. Additional tests for common causes of myocarditis—including parvovirus B19, human herpes virus, Epstein-Barr virus, enterovirus, cytomegalovirus, adenovirus, HIV, and hepatitis C virus—were negative. We therefore concluded that SARS-CoV-2 infection was the most likely cause of our patient’s myocarditis. We gave the patient hydrocortisone at day 11 for 9 days with the aim of reducing inflammation—particularly of the myocardium. The patient was weaned off mechanical ventilation and discharged from the ICU after 3 weeks. We believe this comprehensive description of myocarditis associated with COVID-19 confirms the importance of recent data reporting acute cardiac injury in almost a fifth of patients, with a 50% survival rate. It is recommended that troponin is not routinely measured in patients with COVID-19. However, physicians need to pay heed to the possibility of myocarditis in cases of COVID-19: in cases with high GRACE scores and dynamic ECG changes, usual guidelines to exclude the possibility of an acute myocardial infarction, including measuring troponin and doing an angiogram within 24 h, need to be followed (video).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Craver, R. D., Huber, S., Sandomirsky, M., McKenna, D., Schieffelin, J. S., & Finger, L. (2020) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2020.1761491 · Cited by 140
Plaçais, L., & Richier, Q. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.04.004 · Cited by 96
Cited by
Bhaskar, S., Sinha, A., Banach, M., Mittoo, S., Weissert, R., Kass, J. S., Rajagopal, S., Pai, A. R., & Kutty, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01648 · Cited by 511
Organ-specific manifestations of COVID-19 infection
Gavriatopoulou, M., Korompoki, E., Fotiou, D., Ntanasis-Stathopoulos, I., Psaltopoulou, T., Kastritis, E., Terpos, E., & Dimopoulos, M. A. (2020) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00648-x · Cited by 502
Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis
Figliozzi, S., Masci, P. G., Ahmadi, N., Tondi, L., Koutli, E., Aimo, A., Stamatelopoulos, K., Dimopoulos, M., Caforio, A. L. P., & Georgiopoulos, G. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13362 · Cited by 361
Systematic Review of COVID-19 Related Myocarditis: Insights on Management and Outcome
Sawalha, K., Abozenah, M., Kadado, A. J., Battisha, A., Al-Akchar, M., Salerno, C., Hernandez-Montfort, J., & Islam, A. M. (2021) · Cardiovascular Revascularization Medicine · doi:10.1016/j.carrev.2020.08.028 · Cited by 217
COVID-19 and Myocarditis: Review of Clinical Presentations, Pathogenesis and Management
Lovell, J. P., Division of Cardiology, D. O. M., Čiháková, D., Department of Pathology, J. H. U. O. M., W. Harry Feinstone Department of Molecular Microbiology and Immunology, J. H. U. B. S. O. P. H., Gilotra, N. A., & Division of Cardiology, D. O. M. (2022) · Heart International · doi:10.17925/hi.2022.16.1.20 · Cited by 29
Metadata
- Authors
- Doyen, D., Moceri, P., Ducreux, D., & Dellamonica, J.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 395
- Issue
- 10235
- Pages
- 1516
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W3017508977
- Cited by
- 258
- References
- 2
- FWCI
- 34.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. https://app.cochat.ai/papers/10.1016/s0140-6736(20)30912-0
- The paper
- Doyen, D., Moceri, P., Ducreux, D., & Dellamonica, J. (2020). Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. The Lancet. https://doi.org/10.1016/s0140-6736(20)30912-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.